|
|
|
|
|
11.02.26 - 08:42
|
Dubai Airports CEO: See Resurgence from Chinese Markets (Bloomberg)
|
|
|
More than 95 million travelers arrived at Dubai Airport in 2025 up 3.1% year-on-year, making it the busiest year in the airport's history. Paul Griffiths, CEO of Dubai Airports, spoke to Bloomberg's Horizons Middle East and Africa anchor Joumanna Bercetche on the 2026 outlook for the airport. (Source: Bloomberg)...
|
|
|
|
|
11.02.26 - 08:30
|
Fosun Health to build first overseas hospitals in Indonesia amid Chinese ′go global′ push (SCMP)
|
|
|
Fosun Health Group, a subsidiary of Fosun Pharmaceutical, said it plans to build its first overseas hospitals in Indonesia amid a push by Chinese healthcare companies to expand abroad.
The announcement underscores Indonesia's appeal – home to the world's fourth-largest population of 287 million – as Beijing encourages its healthcare sector to “go global”.
Fosun planned to establish “several hospitals” in Indonesia, CEO Frank Hu Hang told delegates at the South China Morning Post's China......
|
|
|
|
|
|
|
|
|
|
|
|
|
11.02.26 - 07:36
|
Restaurant group XNG′s shares plunge after closure of 10 Shanghai Min outlets (SCMP)
|
|
|
Shares of Hong Kong-listed Shanghai XNG Holdings opened 12 per cent lower on Wednesday, extending Tuesday's plunge of more than 28 per cent, after the company confirmed it had suspended operations at 10 Shanghai Min restaurants in mainland China.
Its shares opened at HK$0.02 on Wednesday. The restaurants serve formal Shanghai cuisine.
In a statement filed with the Hong Kong stock exchange on Tuesday night, the group said the closures were part of a strategic realignment.
The company's struggles......
|
|
|
|
|
|
|
|
|
|
|
11.02.26 - 07:06
|
Capital injection: China backs AI drug makers in self-reliance drive (SCMP)
|
|
|
China's state-backed investors are stepping up funding for artificial intelligence-driven drug developers as Beijing pushes for technological self-reliance, with at least one company already advancing an AI-designed therapy into late-stage clinical trials.
Hangzhou-based METiS TechBio, founded in 2020, raised 400 million yuan in Series D financing in August last year, led by the Beijing Medical and Health Industry Investment Fund and the Daxing Industrial Investment Fund – both government-linked......
|
|
|
|
|
|
|
|
|
11.02.26 - 05:42
|
Pressestimme: ′Handelsblatt′ zu neuen Kaffeeketten aus China (DPA-AFX)
|
|
|
DÜSSELDORF (dpa-AFX) - "Handelsblatt" zu neuen Kaffeeketten aus China:"Ausgerechnet China. Das Land der Teekultur rollt den globalen Café-Markt auf. Mit Kampfpreisen ab 99 Cent für einen Espresso hat die chinesische Kaffeekette Cotti Coffee erste Filialen ......
|
|
|
|